In previous studies, serum apelin levels were found to be lower in many cardiovascular diseases such as coronary artery disease, acute myocardial infarction, advanced heart failure, pulmonary HT, and systemic HT when compared with the control group9,12,16-18. This evidence concerns the gene APLN and myocardial infarction.